Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy

Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy

Saved in:

Bibliographic Details
Main Authors:	Adquate Mhlanga, Ori Wasserman, Pietro Lampertico, Scott J. Cotler, Harel Dahari
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	JHEP Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555924002155
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

Optimizing Hepatitis C Therapy in HIV/hepatitis C Virus (HCV) Coinfected Patients: Analysis of HCV Viral Kinetics on Treatment
by: Paul Damien James, et al.
Published: (2012-01-01)

Hepatitis B Virus Infection in Tanzania: Current Status and Challenges
by: Semvua B. Kilonzo, et al.
Published: (2018-01-01)

Virus Variability and Its Impact on HIV and Hepatitis Therapy
by: Domenico Genovese, et al.
Published: (2012-01-01)

Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago
by: Lan Dam, et al.
Published: (2016-01-01)

The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C
by: Nicholas van Buuren, et al.
Published: (2016-01-01)

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy
by: Janina Bruening, et al.
Published: (2017-01-01)

Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination
by: Apichat Kaewdech, et al.
Published: (2024-12-01)

Challenges faced during antitubercular therapy
by: B. K. Likhitha, et al.
Published: (2024-07-01)

Management of the Kidney Transplant Patient with Chronic Hepatitis C Infection
by: Ignatius Y. S. Tang, et al.
Published: (2011-01-01)

Hepatitis D Virus Status Among People With Hepatitis B Virus Infection: A Disconnect Between Guidelines and Practice
by: Kathryn Jack, et al.
Published: (2024-01-01)

Digital Technology Adoption in the Agriculture Sector: Challenges and Complexities in Africa
by: David Mhlanga, et al.
Published: (2023-01-01)

A Canadian Isolate of Hepatitis D (delta) Virus
by: Véronique Poisson, et al.
Published: (2000-01-01)

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
by: Jona T. Stahmeyer, et al.
Published: (2013-12-01)

Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
by: Elena Franchi, et al.
Published: (2023-12-01)

Acute Coinfection with Hepatitis B and Hepatitis C Viruses
by: Brian M Yan, et al.
Published: (2005-01-01)

Seroprevalence characteristics of hepatitis E virus among blood donors infected with hepatitis B virus
by: YU Qin, et al.
Published: (2025-01-01)

Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China
by: Chengguang Hu, et al.
Published: (2018-01-01)

Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study
by: Oludare ‘Sunbo Adewuyi, et al.
Published: (2025-01-01)

The Laboratory Diagnosis of Hepatitis B Virus
by: Mel Krajden, et al.
Published: (2005-01-01)

Model for hepatitis C virus transmissions
by: Elamin H. Elbasha
Published: (2013-05-01)

Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh
by: Grace Guzman, et al.
Published: (2009-01-01)

Current and future therapeutic options for chronic hepatitis D virus infection
by: Mariantonietta Pisaturo, et al.
Published: (2025-02-01)

Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C
by: CG Nudo, et al.
Published: (2006-01-01)

Diagnosis and management of rheumatic manifestations of Hepatitis B, Hepatitis C and immunodeficiency Virus
by: Arun Ramesh Chogle
Published: (2017-01-01)

Herpes Simplex Virus Hepatitis in an Immunocompetent Host Resembling Hepatic Pyogenic Abscesses
by: Carrie Down, et al.
Published: (2016-01-01)

Issues occult hepatitis B virus infection
by: I. A. Morozov, et al.
Published: (2012-07-01)

Hepatitis C Virus Infection and Mixed Cryoglobulinemia
by: Gianfranco Lauletta, et al.
Published: (2012-01-01)

Challenges in the Diagnosis and Management of Autoimmune Hepatitis
by: Albert J Czaja
Published: (2013-01-01)

Seroprevalences of Hepatitis B Virus and Hepatitis C Virus among Participants of an Asian Health Fair in the Lower Mainland, British Columbia
by: Stephen Ip, et al.
Published: (2015-01-01)

Ischemic Colitis During Pegylated Interferon-Alpha and Ribavirin Therapy for Chronic Hepatitis C
by: Yvette Leung, et al.
Published: (2006-01-01)

Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity
by: Helene Minyi Liu, et al.
Published: (2010-01-01)

Hepatic Encephalopathy Therapy in the ’90s
by: CN Williams
Published: (1994-01-01)

Transitioning to Highly Effective Therapies for the Treatment of Chronic Hepatitis C Virus Infection: A Policy Statement and Implementation Guideline
by: Daniel J Smyth, et al.
Published: (2014-01-01)

Hepatitis C Virus Adaptation to T-Cell Immune Pressure
by: A. Plauzolles, et al.
Published: (2013-01-01)

Hepatitis C Virus, Cryoglobulinemia, and Kidney: Novel Evidence
by: Fabrizio Fabrizi
Published: (2012-01-01)

Effect of Ribavirin on Hepatitis A Virus Replication In Vitro
by: Rabindra K Chaudhary, et al.
Published: (1992-01-01)

In Vitro Systems for the Study of Hepatitis C Virus Infection
by: Garrick K. Wilson, et al.
Published: (2012-01-01)

Antibody to Hepatitis C Virus in Risk Groups in Canada
by: RK Chaudhary, et al.
Published: (1992-01-01)